Breaking

China’s economic slowdown deepens in November as weak demand weigh on growth
Morning brief: SpaceX moves closer to IPO as China slowdown weighs Asian markets
A household name falters: how Roomba maker iRobot slid into bankruptcy
Sanofi shares slide as FDA delays MS drug decision and late-stage trial disappoints
India’s crypto adoption shifts as non-metro cities drive growth: CoinSwitch
Juventus stock jump after Exor rejects Tether’s bid for Agnelli family stake
Japan banks intensify India focus as MUFG nears Shriram Finance deal
Here’s why the IAG share price jumped ~40% in 2025

Business
Investing
Stocks
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Locksley Resources LimitedLt. Gen.Schwartz to Advance US Defense Strategy

December 15, 2025

Uranium Price Forecast: Top Trends for Uranium in 2026

December 15, 2025

Top 5 Canadian Mining Stocks This Week: Sirios Resources Gains 120 Percent

December 13, 2025

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (261)
- Investing (1,549)
- Stocks (1,932)
- World (1,855)

Disclaimer: perfectdaytrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 perfectdaytrading.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.